Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Sanara MedTech Inc. (SMTI)

Sanara MedTech sells Tissue Health Plus assets for about $2 million plus earnout rights

Neutral Impact 2 of 5 restructuring Written later

Sanara MedTech said it sold all assets of its wholly owned subsidiary Tissue Health Plus, LLC, including its business software products and related intellectual property, to an unrelated third party on October 6, 2026. The company received a purchase price of approximately $2,000,000 and certain earnout rights. The filing gives no revenue, profit, or segment figures for the business, so its effect on overall results cannot be assessed from this document.

Key points

  • Asset sale of Tissue Health Plus, LLC completed on October 6, 2026
  • Purchase price of approximately $2,000,000 paid to the company
  • Company also received certain earnout rights, with terms not described in the filing
  • Filed under Item 7.01 Regulation FD Disclosure on October 29, 2026

The filing

CompanySanara MedTech Inc. (SMTI)
Form8-K, current report
Filed with the SECOct 29, 2026, 4:15 PM ET
Accession number0001493152-26-049275

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.